[1] Yang C, Geng H, Zhu S, et al. Multiple diagnostic indicators in the development of chronic hepatitis B, liver cirrhosis, and liver cancer. Altern Ther Health Med, 2023,29(3):153-159. [2] Fan R, Li G, Yu N, et al. aMAP score and its combination with liver stiffness measurement accurately assess liver fibrosis in chronic hepatitis B patients. Clin Gastroenterol Hepatol, 2023,21(12):3070-3079,e13. [3] Tao Y, Wang N, Qiu T, et al. The role of autophagy and NLRP3 inflammasome in liver fibrosis. Biomed Res Int, 2020,2020:7269150. [4] Wu L, Shen Y, Li F. Non-invasive diagnosis of liver fibrosis: A review of current imaging modalities. Gastroenterol Hepatol, 2020,43(4):211-221. [5] 廖卫,石莉,刘秉彦,等. 超声造影与SPTQ技术在肝硬化诊断中的价值. 中国肝脏病杂志(电子版),2020,12(2):25-30. [6] Roh YH, Kang BK, Jun DW, et al. Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center. Sci Rep, 2021,11(1):13616. [7] Moosavy SH, Eftekhar E, Davoodian P, et al. AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran. BMC Gastroenterol, 2023,23(1):145. [8] 中华医学会肝病学分会;中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版). 实用肝脏病杂志,2016,19(3):389-400. [9] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年). 实用肝脏病杂志,2019,22(6):793-803. [10] Tseng TC, Liu CJ, Su TH, et al. Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection. Aliment Pharmacol Ther, 2018,47(11):1480-1489. [11] 单姗,赵连晖,马红,等. 肝硬化的定义、病因及流行病学. 临床肝胆病杂志,2021,37(1):14-16. [12] Lim SG, Baumert TF, Boni C, et al.The scientific basis of combination therapy for chronic hepatitis B functional cure. Nat Rev Gastroenterol Hepatol,2023,20(4):238-253. [13] 牛志强,李智伟. 慢性乙型肝炎肝纤维化无创诊断方法的研究进展. 中华传染病杂志,2022,40(2):116-120. [14] 杨晴,王岩,关欣,等. 无创模型在慢性乙型肝炎肝纤维化诊断中的价值. 世界华人消化杂志,2020,28(22):1137-1144. [15] 李雪齐,程广文,梁静,等. 剪切波频散成像和弹性成像联合血清学指标的预测模型在肝纤维化分期中的应用价值. 中华医学杂志,2023,103(29):2246-2251. [16] 董丙田,黄枢,常建东,等. 声触诊弹性成像与4项血清纤维化指标评估慢性乙型肝炎肝纤维化的效能比较. 中华肝脏病杂志,2020,28(3):269-272. [17] 田婧,何岩莉,骈林萍,等. SPTQ联合天门冬氨酸氨基转移酶/血小板比值对慢性乙型肝炎患者肝纤维化分期的诊断价值研究. 实用肝脏病杂志,2018,21(2):216-219. [18] Amernia B, Moosavy SH, Banookh F, et al FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran. BMC Gastroenterol, 2021,21(1):453. [19] Liu H, Li H, Deng G, et al. Association of AST/ALT ratio with 90-day outcomes in patients with acute exacerbation of chronic liver disease: a prospective multicenter cohort study in China. Front Med (Lausanne), 2024,11:1307901. [20] 代海峰,王甜,雷迅,等. 应用瞬时弹性成像技术联合APRI和AAR指数评估慢性乙型肝炎患者肝纤维化临床价值研究. 实用肝脏病杂志,2021,24(2):196-199. |